Tryptamine Therapeutics Limited (ASX:TYP)

Tryptamine Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Cash & Equivalents	3.03	5.33	0.44	2.02	3.93
Cash & Short-Term Investments	3.03	5.33	0.44	2.02	3.93
Cash Growth	-43.19%	1102.96%	-78.04%	-48.73%	271.83%
Other Receivables	2.76	1.44	0.07	0.01	0.02
Receivables	2.76	1.44	0.07	0.01	0.02
Prepaid Expenses	0.56	0.31	0.04	0.32	0.4
Restricted Cash	-	-	-	0.08	0.06
Total Current Assets	6.35	7.08	0.55	2.42	4.42
Property, Plant & Equipment	0.11	-	-	-	-
Other Intangible Assets	0.2	0.37	0.2	0.18	0.03
Other Long-Term Assets	0	0	-	-	-
Total Assets	6.66	7.45	0.75	2.6	4.45
Accounts Payable	0.22	1.27	2.09	1.28	0.2
Accrued Expenses	0.47	0.36	0.15	0.05	0
Short-Term Debt	-	0.2	-	-	-
Other Current Liabilities	0.01	0	0.01	-	-
Total Current Liabilities	0.7	1.83	2.25	1.33	0.2
Long-Term Debt	-	-	2.4	-	-
Other Long-Term Liabilities	-	-	0.39	-	-
Total Liabilities	0.7	1.83	5.04	1.33	0.2
Common Stock	35.31	29.91	15.09	15.03	10.49
Additional Paid-In Capital	-	-	-	3.52	3.15
Retained Earnings	-35.41	-30.07	-23.93	-18.01	-9.39
Comprehensive Income & Other	6.06	5.78	4.55	0.73	-
Shareholders' Equity	5.96	5.62	-4.29	1.27	4.25
Total Liabilities & Equity	6.66	7.45	0.75	2.6	4.45
Total Debt	-	0.2	2.4	-	-
Net Cash (Debt)	3.03	5.13	-1.96	2.02	3.93
Net Cash Growth	-40.99%	-	-	-48.73%	273.49%
Net Cash Per Share	0.00	0.01	-0.01	0.03	0.08
Filing Date Shares Outstanding	1,390	1,139	93.38	87.29	51.45
Total Common Shares Outstanding	1,439	1,139	93.38	87.29	51.45
Working Capital	5.65	5.25	-1.7	1.09	4.22
Book Value Per Share	0.00	0.00	-0.05	0.01	0.08
Tangible Book Value	5.77	5.25	-4.49	1.09	4.22
Tangible Book Value Per Share	0.00	0.00	-0.05	0.01	0.08
Machinery	0.13	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.